Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 424-820-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
OECD 401: The acute oral LD50 is >2000 mg/kg bw.
OECD 402: The acute dermal LD50 is >500 mg/kg bw.
Recorded minor effects derive from the corrosive nature of the substance
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- GLP study conducted according to OECD guideline 401. Klimisch 2. The available information comprises an adequate , reliable (Klimish score 2) study, which is sufficient to fulfil the standard information requirements set out in Annex VII, 8.5 of Regulation (EC) No. 1907/2006.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 500 mg/kg bw
- Quality of whole database:
- GLP study conducted accroding to OECD guideline 402. Klimisch 2.
Additional information
The acute oral toxicity study was conducted in accordance with OECD guideline 401 and EU Method B1, the study was to GLP standard. The registration substance has an LD50 of greater than 2000 mg/kg bodyweight, with only a single treatment related death observed during the study.
The acute dermal toxicity study was conducted in accordance with OECD guideline 402 and to GLP standard. The registration substance had an LD50 of greater than 500 mg/kg bodyweight, this was the maximum concentration tested in the study due to the corrosive nature of the substance. It is considered that the LD50 is greater than 1000 mg/kg bodyweight as no deaths were observed at 500 mg/kg bodyweight and toxicity was limited to severe dermal irritation at the application site. However due to the corrosive nature of the registration substance it can not be said with confidence that the LD50 would be greater than 2000 mg/kg bodyweight. This assessment is used to aid in the classification and labelling of the registration for acute dermal toxicity.
In accordance with Column 2 of Annex VIII, section 8.5.2 of the REACH Regulation, a study of the acute inhalation toxicity is not required, since studies of acute toxicity via oral exposure and via dermal exposure have been provided. Furthermore this is not considered a relevant route of exposure based on the physical-chemical properties of the registration substance. EC 424-820-7 is a liquid with negligible vapour pressure (0.511 Pa at 23 °C). The use of the substance is not anticipated to result in the formation of aerosols, particles or droplets of inhalable size. Thus, exposure of humans via inhalation is unlikely. Therefore, testing for acute toxicity by the inhalation route is not appropriate and should be avoided for reasons of animal welfare.
Justification for selection of acute toxicity – oral endpoint
Key Study: Klimisch 2. The reliable GLP compliant OECD guideline study was chosen.
Justification for selection of acute toxicity – inhalation endpoint
In accordance with Column 2, section 8.5.2 of Annex VIII of the REACH Regulation, a study of the acute inhalation toxicity of the test substance is not required, since studies of the acute toxicity of the test substance via oral exposure and via dermal exposure have been provided (see Sections 7.2.1 and 7.2.3 of the IUCLID dossier).
Justification for selection of acute toxicity – dermal endpoint
Key Study: Klimisch 2. The reliable GLP compliant OECD guideline study was chosen. The available information comprises an adequate, reliable (Klimish score 1) study, which is sufficient to fulfil the standard information requirements set out in Annex VII, 8.5 of Regulation (EC) No. 1907/2006.
Justification for classification or non-classification
The acute oral toxicity study was conducted in accordance with OECD guideline 401 and to GLP standard. The registration material had an LD50 of greater than 2000 mg/kg body weight, with only one treatment related death observed during the study. Therefore the registration material does not require classification for acute oral toxicity under Regulation (EC) No 1272/2008 (CLP).
The acute dermal toxicity study was conducted in accordance with OECD guideline 402 and to GLP standard. The registration material had an LD50 of greater than 500 mg/kg bodyweight, this was the maximum concentration tested in the study due to the corrosive nature of the material. It is considered that the LD50 is greater than 1000 mg/kg bodyweight as no deaths were observed at 500 mg/kg bodyweight and toxicity was limited to severe dermal irritation at the application site. However due to the corrosive nature of the registration material it can not be said with confidence that the LD50 would be greater than 2000 mg/kg bodyweight. Therefore in accordance with Regulation (EC) No 1272/2008, the material will be classified as H312: Harmful in contact with skin.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.